北京市金杜（青岛）律师事务所 关于海利尔药业集团股份有限公司 2025 年限制性股票激励计划首次授予事项的 法律意见书 致：海利尔药业集团股份有限公司 北京市金杜（青岛）律师事务所（以下简称金杜或本所）接受海利尔药业集 团股份有限公司（以下简称海利尔或公司）委托，作为其实施 2025 年限制性股 票激励计划（以下简称本激励计划、本次激励计划或本计划）的专项法律顾问， 根据《中华人民共和国公司法》（以下简称《公司法》）、《中华人民共和国证 券法》（以下简称《证券法》）、中国证券监督管理委员会（以下简称中国证监 会）《上市公司股权激励管理办法》（以下简称《管理办法》）、《上海证券交 易所股票上市规则》（以下简称《上市规则》）、《上海证券交易所上市公司自 律监管指南第 2 号——业务办理》（以下简称《业务办理指南》）等法律、行政 法规、部门规章及规范性文件（以下简称法律法规）和《海利尔药业集团股份有 限公司章程》（以下简称《公司章程》）、《海利尔药业集团股份有限公司 2025 年限制性股票激励计划（草案）》（以下简称《激励计划（草案）》）的有关规 定，就公司本激励计划首次授予（以下简称本次授予）所涉及的相关事项，出 ...

Market Overview - The agricultural chemical sector experienced a decline of 0.75% on October 30, with Hai Li Er leading the drop [1] - The Shanghai Composite Index closed at 3986.9, down 0.73%, while the Shenzhen Component Index closed at 13532.13, down 1.16% [1] Stock Performance - Notable gainers in the agricultural chemical sector included: - Dongfang Tieta (002545) with a closing price of 17.71, up 2.61% and a trading volume of 382,500 shares [1] - Yuntu Holdings (002539) closed at 10.64, up 2.41% with a trading volume of 384,900 shares [1] - Hualu Hengsheng (600426) closed at 25.75, up 1.90% with a trading volume of 191,200 shares [1] - Major decliners included: - Hai Li Er (603639) closed at 13.44, down 9.98% with a trading volume of 151,800 shares [2] - Changqing Co., Ltd. (002391) closed at 6.07, down 6.76% with a trading volume of 614,600 shares [2] - Yangnong Chemical (600486) closed at 64.81, down 4.85% with a trading volume of 88,300 shares [2] Capital Flow - The agricultural chemical sector saw a net outflow of 850 million yuan from institutional investors, while retail investors contributed a net inflow of 695 million yuan [2][3] - The main capital inflow and outflow for selected stocks included: - Dongfang Tieta (002545) had a net inflow of 77.12 million yuan from institutional investors [3] - Hualu Hengsheng (600426) experienced a net inflow of 50.55 million yuan from institutional investors [3] - Hai Li Er (603639) saw a significant net outflow of 20.7 million yuan from institutional investors [3]

Group 1 - Company Hailier (SH 603639) announced on October 29 that its 11th meeting of the 5th Board of Directors was held via communication voting on October 29, 2025 [1] - The meeting reviewed the proposal regarding the company's Q3 2025 report and other documents [1] Group 2 - As of the time of reporting, Hailier's market capitalization is 5.1 billion yuan [2]

证券代码：603639 证券简称：海利尔 公告编号：2025-055 海利尔药业集团股份有限公司 2025 年三季度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 | 甲苯 | 0.53 | 0.65 | -17.54 | | --- | --- | --- | --- | | 一甲胺精品 | 0.42 | 0.40 | 3.37 | | 液氯 | 0.003 | 0.031 | -89.19 | 四、其他对公司生产经营具有重大影响的事项 以上生产经营数据，来自公司内部统计，未经审计，仅为投资者及时了解公 司生产经营概况之用，未对公司未来经营情况作出任何明示或默示的预测或保 证。公司董事会提醒投资者审慎使用上述数据。 根据《上海证券交易所上市公司自律监管指引第 3 号—行业信息披露》之 《上市公司行业信息披露指引第十三号—化工》要求，海利尔药业集团股份有限 公司（以下简称"公司"）现将 2025 年三季度主要经营数据披露如下： 一、主要产品的产量、销量及收入实现情况（不含税） | 2025 | 年 | 1 | ...

证券代码：603639 证券简称：海利尔 公告编号：2025-056 海利尔药业集团股份有限公司 2025年第一次临时股东会决议公告 (二)股东会召开的地点：青岛市城阳区国城路 216 号公司五楼会议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 124 | | --- | --- | | 2、出席会议的股东所持股份总数（股） | 164,597,078 | | 3、出席会议的股东所持股份数占公司有表决权股份总数的 | | | 比例（%） | 48.4282 | (四)表决方式是否符合《公司法》及《公司章程》的规定，股东会主持情况等。 本次股东会由董事会召集，采用现场投票和网络投票相结合的方式召开，董 事长葛家成先生因出差在外无法出席本次会议，经过半数以上董事推举董事陈萍 先生代为主持会议。本次股东会的表决方式、表决程序及表决结果符合《公司法》 《股东会规则》 等法律法规、规范性文件及《公司章程》的有关规定。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要 ...

证券代码：603639 证券简称：海利尔 公告编号：2025-053 海利尔药业集团股份有限公司 关于公司第五届董事会第十一次会议决议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 海利尔药业集团股份有限公司(以下简称"公司")第五届董事会第十一次会议 于 2025 年 10 月 29 日以通讯表决的方式召开。会议通知于 2025 年 10 月 25 日以电 子邮件的方式发出，会议应到董事 9 名，实到董事 8 名，葛尧伦先生因个人原因未 出席会议。本次会议的召集和召开符合《中华人民共和国公司法》和《海利尔药业 集团股份有限公司章程》的有关规定，合法有效。 二、董事会会议审议情况 相关内容详见同日在上海证券交易所网站上披露的《海利尔药业集团股份有限 公司 2025 年第三季度报告》。 表决结果：同意票 8 票，反对票 0 票，弃权票 0 票。 本议案经公司董事会审计委员会审议通过后提交董事会审议。 2、审议通过《关于公司 2025 年三季度主要经营数据的议案》 相关内容详见同日在上海证券交易所网 ...

证券代码：603639 证券简称：海利尔 公告编号：2025-057 海利尔药业集团股份有限公司 关于 2025 年限制性股票激励计划内幕信息知情人 买卖公司股票情况的自查报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 3、本公司向中国证券登记结算有限责任公司就核查对象在自查期间买卖公 司股票的情况进行了查询确认，并由中国证券登记结算有限责任公司出具了《信 息披露义务人持股及股份变更查询证明》 《股东股份变更明细清单》。 二、核查对象买卖本公司股票的情况说明 根据中国证券登记结算有限责任公司出具的《信息披露义务人持股及股份变 更查询证明》及《股东股份变更明细清单》，在激励计划自查期间，所有核查对 象均不存在买卖公司股票的情况。 三、结论 综上所述，公司严格按照相关法律、法规及规范性文件的规定，建立了信息 披露及内幕信息管理的相关制度；公司本次股权激励计划策划、讨论过程中已按 照上述规定采取了相应保密措施，限定了接触内幕信息人员的范围，对接触到内 幕信息的相关公司人员及中介机构及时进行了登记；公司在本激励计划公告前， 未发 ...

北京市金杜（青岛）律师事务所（以下简称本所）接受海利尔药业集团股份 有限公司（以下简称公司）的委托，根据本法律意见书出具日前已经发生或存在 的事实和《中华人民共和国公司法》（以下简称《公司法》）、《中华人民共和 国证券法》（以下简称《证券法》）、《上市公司股东会规则》（以下简称《股 东会规则》）等中华人民共和国境内（以下简称中国境内，为本法律意见书之目 的，不包括中国香港特别行政区、中国澳门特别行政区和中国台湾省）现行有效 的法律、法规和规范性文件以及现行有效的《海利尔药业集团股份有限公司章程》 （以下简称《公司章程》）的有关规定，指派律师出席了公司于2025年10月29 日召开的2025年第一次临时股东会（以下简称本次股东会），并就本次股东会的 相关事项出具本法律意见书。 北京市金杜（青岛）律师事务所 关于海利尔药业集团股份有限公司 2025 年第一次临时股东会之法律意见书 致：海利尔药业集团股份有限公司 为出具本法律意见书，本所律师审查了公司提供的以下文件，包括但不限于： 1. 经公司 2024 年年度股东大会审议通过的《公司章程》； 2. 公司 2025 年 9 月 30 日披露于巨潮资讯网（http: ...

Financial Performance - The company's operating revenue for the third quarter was ¥781,925,704.44, a decrease of 3.19% compared to the same period last year[4] - The total profit for the quarter was ¥9,617,976.19, reflecting a significant decline of 73.19% year-over-year[4] - The net profit attributable to shareholders was ¥6,449,235.82, down 80.89% compared to the previous year[4] - The net profit after deducting non-recurring gains and losses was ¥2,625,916.85, a decrease of 83.78% year-over-year[4] - The basic earnings per share for the quarter was ¥0.02, a decline of 79.18% compared to the same period last year[5] - The diluted earnings per share also stood at ¥0.02, down 79.22% year-over-year[5] - The weighted average return on equity was 0.24%, a decrease of 75.52% compared to the previous year[5] - Total operating revenue for the first three quarters of 2025 reached ¥3,390,781,300.03, an increase of 5.52% compared to ¥3,213,879,407.17 in the same period of 2024[19] - Total operating costs for the first three quarters of 2025 were ¥3,109,738,427.51, up from ¥2,940,226,911.15 in 2024, reflecting a year-on-year increase of 5.77%[19] - Net profit for the first three quarters of 2025 was ¥207,919,470.53, compared to ¥195,873,110.79 in 2024, representing an increase of 6.00%[20] - The company's earnings per share (EPS) for the first three quarters of 2025 was ¥0.61, up from ¥0.58 in the same period of 2024[21] - The company reported a tax expense of ¥40,966,815.03 for the first three quarters of 2025, compared to ¥30,683,337.52 in 2024, reflecting a significant increase of 33.47%[20] - Other comprehensive income after tax for the first three quarters of 2025 was ¥329,567.60, compared to a loss of ¥41,634.30 in the same period of 2024[21] Assets and Liabilities - Total assets at the end of the quarter were ¥6,976,700,595.97, an increase of 1.64% from the end of the previous year[5] - Shareholders' equity attributable to the parent company was ¥3,461,061,411.34, up 1.09% from the previous year[5] - The company's total current assets as of September 30, 2025, amount to ¥3,768,049,240.10, an increase from ¥3,674,877,593.55 at the end of 2024[15] - Accounts receivable increased to ¥1,197,512,726.74 from ¥873,216,631.07, indicating a growth of approximately 37.1%[15] - Total assets as of September 30, 2025, are ¥6,976,700,595.97, compared to ¥6,864,016,889.81 at the end of 2024[16] - Total current liabilities decreased to ¥3,060,793,285.72 from ¥3,226,389,446.91, a reduction of about 5.1%[16] - Total liabilities as of the reporting date were ¥3,515,639,184.63, compared to ¥3,440,203,095.45 in the previous year, indicating an increase of 2.19%[17] - Total equity attributable to shareholders reached ¥3,461,061,411.34, up from ¥3,423,813,794.36, marking a growth of 1.09%[17] - The total assets of the company amounted to ¥6,976,700,595.97, an increase from ¥6,864,016,889.81 in the previous year, indicating a growth of 1.63%[17] Cash Flow - The cash flow from operating activities for the year-to-date was ¥50,553,565.76, a decrease of 15.85% compared to the same period last year[5] - Net cash inflow from operating activities was $50,553,565.76, a decrease of 15.4% compared to $60,074,495.09 in the previous period[24] - Cash flow from operating activities for the first three quarters of 2025 was ¥2,186,919,372.76, slightly up from ¥2,182,606,535.03 in 2024[23] - Total cash inflow from investment activities was $925,045,880.27, up from $749,853,330.07, reflecting a growth of 23.4%[24] - Cash outflow from investment activities decreased to $983,685,621.52 from $1,222,399,759.59, indicating a reduction of 19.6%[24] - Net cash flow from financing activities was $269,911,765.11, down 48.8% from $526,477,899.42 in the previous period[25] - Total cash and cash equivalents at the end of the period reached $440,897,923.51, an increase of 54% compared to $286,238,262.92[25] - Cash received from borrowings amounted to $1,392,044,827.58, significantly higher than $832,341,820.55 previously, marking a rise of 67.5%[25] - Cash paid for the purchase of fixed assets and intangible assets was $132,714,333.27, down from $242,543,319.57, a decrease of 45.4%[24] - Cash received from investment income was $4,461,209.65, down from $10,469,153.74, a decline of 57.3%[24] - Cash received from other financing activities totaled $1,316,694,952.12, compared to $789,517,251.15, an increase of 67%[25] - The impact of exchange rate changes on cash and cash equivalents was a negative $1,129,619.32, contrasting with a positive impact of $679,126.84 previously[25] Shareholder Information - Total number of common shareholders at the end of the reporting period is 12,958[12] - The largest shareholder, Zhang Aiying, holds 127,253,000 shares, representing 37.43% of total shares[12] - The company has no significant changes in the top 10 shareholders or their shareholding status compared to the previous period[13] Strategic Developments - There are no new strategies or significant developments reported in the conference call[14]

Core Viewpoint - The pesticide sector experienced a significant rally in the afternoon, with multiple companies reaching their daily price limits [1] Company Performance - Changqing Co. and Yangnong Chemical both hit the daily limit up [1] - Liming Co., Runfeng Co., Hailier, Xin'an Co., and Guangxin Co. also saw increases in their stock prices [1]